title: Primary prevention with statins is more cost-effective.
authors.forename: J
authors.initials: J
authors.lastname: Aalbers
mesh_terms: D002097:C-Reactive Protein / Q000032:analysis; D002170:Canada; D050171:Dyslipidemias / Q000188:drug therapy* / Q000191:economics; D005464:Fluorobenzenes / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D011322:Primary Prevention; D011743:Pyrimidines / Q000627:therapeutic use; D000068718:Rosuvastatin Calcium; D019821:Simvastatin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
chemical_list: D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D002097:C-Reactive Protein; D019821:Simvastatin